Alimera Sciences Debt/Equity
What is the Debt/Equity of Alimera Sciences?
The Debt/Equity of Alimera Sciences Inc. is 2.33
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Health Care sector on NASDAQ compared to Alimera Sciences
What does Alimera Sciences do?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Companies with debt/equity similar to Alimera Sciences
- PNC Infratech has Debt/Equity of 2.32
- Orca Exploration has Debt/Equity of 2.32
- Orca has Debt/Equity of 2.32
- Skywest has Debt/Equity of 2.32
- Seneca Foods has Debt/Equity of 2.32
- Krungthai Card Public has Debt/Equity of 2.32
- Alimera Sciences has Debt/Equity of 2.33
- Afarak Oyj has Debt/Equity of 2.33
- Gateway Real Estate AG has Debt/Equity of 2.33
- I.T has Debt/Equity of 2.33
- Dwarikesh Sugar Industries has Debt/Equity of 2.33
- Artesian Resources has Debt/Equity of 2.33
- Argonaut Resources NL has Debt/Equity of 2.33